FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

430048000: Product containing sulfacetamide in vaginal dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2009. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3711980018 Product containing sulfacetamide in vaginal dose form (medicinal product form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3711981019 Sulfacetamide-containing product in vaginal dose form en Synonym Active Entire term case insensitive SNOMED CT core module


5 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing sulfacetamide in vaginal dose form (medicinal product form) Is a Product containing sulfacetamide true Inferred relationship Existential restriction modifier
Product containing sulfacetamide in vaginal dose form (medicinal product form) Has active ingredient Sulfacetamide true Inferred relationship Existential restriction modifier 1
Product containing sulfacetamide in vaginal dose form (medicinal product form) Has manufactured dose form Vaginal dose form true Inferred relationship Existential restriction modifier
Product containing sulfacetamide in vaginal dose form (medicinal product form) Is a Product manufactured as vaginal dose form true Inferred relationship Existential restriction modifier
Product containing sulfacetamide in vaginal dose form (medicinal product form) Plays role Antibacterial therapeutic role true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing sulfabenzamide and sulfacetamide and sulfathiazole Is a False Product containing sulfacetamide in vaginal dose form (medicinal product form) Inferred relationship Existential restriction modifier
Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) Is a False Product containing sulfacetamide in vaginal dose form (medicinal product form) Inferred relationship Existential restriction modifier
Sulfabenzamide+sulfacetamide+sulfathiazole 3.7%/2.86%/3.42% vaginal cream Is a False Product containing sulfacetamide in vaginal dose form (medicinal product form) Inferred relationship Existential restriction modifier
Product containing only sulfacetamide in vaginal dose form (medicinal product form) Is a True Product containing sulfacetamide in vaginal dose form (medicinal product form) Inferred relationship Existential restriction modifier
Product containing sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) Is a True Product containing sulfacetamide in vaginal dose form (medicinal product form) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start